| RS121434474 |
MT-TH
|
Health Risk |
Likely pathogenic |
MERRF/MELAS overlap syndrome, MELAS syndrome |
| RS121434478 |
ATIC
|
Health Risk |
Conflicting classifications of pathogenicity |
AICA-ribosiduria, See cases |
| RS121434479 |
NDUFS7
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 3 |
| RS121434480 |
HPGD
|
Health Risk |
Pathogenic |
Cranioosteoarthropathy, Hypertrophic osteoarthropathy |
| RS121434481 |
HPGD
|
Health Risk |
Likely pathogenic |
Isolated congenital digital clubbing, Isolated congenital digital clubbing |
| RS121434482 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS121434483 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS121434484 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Subcortical band heterotopia, Subcortical band heterotopia |
| RS121434485 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS121434486 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS121434487 |
PAFAH1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS121434488 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Subcortical band heterotopia, Subcortical band heterotopia |
| RS121434489 |
PAFAH1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lissencephaly due to LIS1 mutation, Subcortical band heterotopia |
| RS121434490 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS121434491 |
EFEMP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Doyne honeycomb retinal dystrophy, Retinal dystrophy |
| RS121434492 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, IL12RB1-related disorder |
| RS121434493 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS121434494 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS121434495 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS121434496 |
SMARCB1
|
Health Risk |
Pathogenic |
Schwannomatosis 1, somatic |
| RS121434497 |
MAP2K2
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 4, Cardio-facio-cutaneous syndrome |
| RS121434498 |
MAP2K2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 4, Cardio-facio-cutaneous syndrome |
| RS121434499 |
MAP2K2
|
Health Risk |
Pathogenic |
Cardio-facio-cutaneous syndrome, Cardiofaciocutaneous syndrome 4 |
| RS121434500 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 12, Long QT syndrome |
| RS121434501 |
CAV1
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 3, Partial lipodystrophy |
| RS121434502 |
RANBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial acute necrotizing encephalopathy, See cases |
| RS121434503 |
RANBP2
|
Health Risk |
risk factor |
Familial acute necrotizing encephalopathy, Familial acute necrotizing encephalopathy |
| RS121434504 |
RANBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial acute necrotizing encephalopathy, Familial acute necrotizing encephalopathy |
| RS121434505 |
FANCE
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS121434506 |
FANCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS121434507 |
PTPRJ
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS121434508 |
TMEM126A
|
Health Risk |
Pathogenic |
Autosomal recessive optic atrophy, OPA7 type |
| RS121434511 |
PNKD
|
Health Risk |
Pathogenic/Likely pathogenic |
Paroxysmal nonkinesigenic dyskinesia 1, Paroxysmal dyskinesia |
| RS121434512 |
PNKD
|
Health Risk |
Pathogenic/Likely pathogenic |
Paroxysmal nonkinesigenic dyskinesia 1, Paroxysmal nonkinesigenic dyskinesia |
| RS121434513 |
PNKD
|
Health Risk |
Conflicting classifications of pathogenicity |
Paroxysmal nonkinesigenic dyskinesia 1, Paroxysmal nonkinesigenic dyskinesia |
| RS121434514 |
KIFBP
|
Health Risk |
Pathogenic |
Goldberg-Shprintzen syndrome, Goldberg-Shprintzen syndrome |
| RS121434515 |
KIFBP
|
Health Risk |
Pathogenic |
Goldberg-Shprintzen syndrome, Goldberg-Shprintzen syndrome |
| RS121434516 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS121434517 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi Goutieres syndrome |
| RS121434518 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS121434519 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Chilblain lupus 2 |
| RS121434520 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS121434522 |
RNF6
|
Health Risk |
Pathogenic |
Esophageal squamous cell carcinoma, somatic |
| RS121434523 |
RNF6
|
Health Risk |
Pathogenic |
Esophageal squamous cell carcinoma, somatic |
| RS121434524 |
RNF6
|
Health Risk |
Pathogenic |
Esophageal squamous cell carcinoma, somatic |
| RS121434525 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary dilated cardiomyopathy |
| RS121434526 |
ACTA2
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS121434527 |
ACTA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS121434528 |
ACTA2
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS121434529 |
NAGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency |
| RS121434530 |
NAGA
|
Health Risk |
Likely pathogenic |
Alpha-N-acetylgalactosaminidase deficiency, Alpha-N-acetylgalactosaminidase deficiency type 2 |
| RS121434531 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 2 |
| RS121434532 |
NAGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-N-acetylgalactosaminidase deficiency type 3, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS121434533 |
NAGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS121434534 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS121434536 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS121434538 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase excess syndrome |
| RS121434542 |
CDH3
|
Health Risk |
Pathogenic |
Congenital hypotrichosis with juvenile macular dystrophy, Retinal dystrophy |
| RS121434543 |
CDH3
|
Health Risk |
Pathogenic |
EEM syndrome, EEM syndrome |
| RS121434544 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS121434545 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS121434546 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS121434547 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS121434548 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS121434549 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS121434550 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS121434552 |
CA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 17, Retinal dystrophy |
| RS121434553 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1C |
| RS121434554 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1C |
| RS121434555 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1C, Bethlem myopathy 1C |
| RS121434558 |
GJA5
|
Health Risk |
Pathogenic |
Atrial fibrillation, somatic |
| RS121434559 |
PPIB
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 9, Osteogenesis imperfecta type 9 |
| RS121434560 |
LIG1
|
Health Risk |
Pathogenic |
Immunodeficiency 96, Immunodeficiency 96 |
| RS121434561 |
LIG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 96, Immunodeficiency 96 |
| RS121434562 |
TOP1
|
Health Risk |
Pathogenic |
DNA topoisomerase I, camptothecin-resistant |
| RS121434563 |
EGR2
|
Health Risk |
Pathogenic |
Dejerine-sottas neuropathy, autosomal dominant |
| RS121434564 |
EPB41
|
Health Risk |
Pathogenic |
Elliptocytosis 1, Elliptocytosis 1 |
| RS121434567 |
EGF
|
Health Risk |
Pathogenic |
Renal hypomagnesemia 4, Renal hypomagnesemia 4 |
| RS121434570 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group G |
| RS121434571 |
ERCC5
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group G |
| RS121434572 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group G/Cockayne syndrome, Xeroderma pigmentosum group G/Cockayne syndrome |
| RS121434573 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group G/Cockayne syndrome, Xeroderma pigmentosum group G/Cockayne syndrome |
| RS121434574 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group G/Cockayne syndrome, Xeroderma pigmentosum group G/Cockayne syndrome |
| RS121434575 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group G |
| RS121434577 |
ERCC5
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group G |
| RS121434578 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS121434579 |
GABRA1
|
Health Risk |
risk factor |
Epilepsy, idiopathic generalized |
| RS121434580 |
GABRD
|
Health Risk |
risk factor |
Generalized epilepsy with febrile seizures plus type 5, Generalized epilepsy with febrile seizures plus type 5 |
| RS121434581 |
SLC2A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS121434582 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALDH18A1-related de Barsy syndrome, Cutis laxa |
| RS121434583 |
ALDH18A1
|
Health Risk |
Pathogenic |
ALDH18A1-related de Barsy syndrome, ALDH18A1-related de Barsy syndrome |
| RS121434584 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS121434585 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS121434587 |
IGF2R
|
Health Risk |
Pathogenic |
Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS121434588 |
IGF2R
|
Health Risk |
Pathogenic |
Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS121434589 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS121434590 |
MYH8
|
Health Risk |
Pathogenic |
Hecht syndrome, Carney complex - trismus - pseudocamptodactyly syndrome |
| RS121434591 |
MATR3
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 21, Amyotrophic lateral sclerosis type 21 |
| RS121434592 |
AKT1
|
Health Risk |
Pathogenic |
Breast adenocarcinoma, Carcinoma of colon |
| RS121434593 |
AKT2
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |